Researchers from Imperial College London, led by Dr. Paolo Muraro, have refined a stem cell treatment for Multiple Sclerosis (MS); using the patient’s own stem cells to reset the immune system and “freeze” the disease. MS is a disease in which the body’s immune system attacks the protective sheath (myelin) that covers nerve fibers thereby causing communication disruptions between the brain and the rest of the body. The treatment works by first recovering healthy stem cells from the patient and then, using high-dose chemotherapy to kill the remaining damaged immune cells. Reintroducing the recovered stem cells into the patient’s body reboots the immune system and halts the disease.
According to Dr Paolo Muraro, "We previously knew this treatment reboots or resets the immune system - and that it carried risks - but we didn't know how long the benefits lasted. The study found that 46% of patients with MS, and 73% of patients with relapsing MS, who underwent the treatment did not have a worsening condition for 5 years.
This advancement in MS treatment demonstrates the best stem cells to use will be the patient’s own [autologous stem cells] as this negates the need to find a suitable donor and eliminates the chances of rejection of the transplanted tissue. To learn how to bank your own valuable stem cells to insure your future health, visit www.StemSave.com or call 877-783-6728 (877-StemSave) today.
The Future of Regenerative Medicine is Now™
To view the full article, click here.